Dismal day again on Wall Street as Unemployment Data showed 500,000 new jobless claims and increased fears of a double dip recession are mounting. Also, a fear in tax hikes with the end of Bush Tax cuts ending in 135 days. The economy is very nervous and jittery. Luckily BioPharma plays can go up regardless of all of this negative news. Unfortunately, not as much as they used to because of nervous investors who sell, sell, sell before FDA decisions. I understand though. I wouldn't want to lose a lot of money because of a negative recommendation either. Sometimes you have to go with your gut on some things and let it ride.
Big news with Intel buying McAfee for a premium as McAfee's stock rose 57%. But the BioPharma market painted a different picture with most stocks down for the day between 1-2% overall. Tomorrow is a big day for Jazz Pharma with FDA recommendation panel for their Fibramyalgia medication. I expect approval and a strong day for Jazz. If not then it will go down heavily. But I just don't see that happening as the medication is already approved for Necrolepsy. There is a huge safety concern for the medication as outlined in yesterday's Wall St. Journal article FDA Raises Concerns About Fibromyalgia Drug. This being said I am letting it ride tomorrow and if it goes up it goes up, if it goes down it goes down. We will see.
Investment plays I currently like are BioElectronics BIEL, Amarin AMRN, and Exact Sciences EXAS. Jiangbo Pharmaceuticals JGBO has been gaining strength lately with a Strong Buy rating, Endo Pharmaceuticals ENDO, and KV Pharmaceuticals KVA.
Thursday's Top Performing Pharmaceuticals
Showing posts with label Top Performing Biotech Pharmaceuticals Stocks. Show all posts
Showing posts with label Top Performing Biotech Pharmaceuticals Stocks. Show all posts
8/18/10
Top Performing Biotech and Pharmaceuticals for Wednesday August 18th
Image via CrunchBase Today was a good day for recommendations and Friday gets even better with Jazz Pharmaceuticals presenting August 20th to the FDA for their Fibramyalgia medication JZP-6 sodium oxybate. Jazz had huge gains this morning as the FDA handed out their review of the clinical trial. Jazz shot up around the 11.90 mark and has been so oversold that right now it's pushing 10.49 in afterhours trading. It has been All Over The Map Today. Speaking of all over the map, BSD Medical exploded today with their medical device approval from the FDA. Just exploded all over the map. What a day. Jazz was disappointing in the fact that everyone sold. Everyone is scared to death to leave it in the market for the FDA decision. Shoot the dice and let it roll sometimes. But we know where most people stand on this one. I'm taking my profits and waiting for tomorrow where I kick myself for selling. This one's a no-brainer in my department for Approval tomorrow.
Top Performing Biotech Stocks for Wednesday August 18th
8/17/10
Biotech and Pharmaceuticals Top Performers Tuesday's Edition
Big Day today in the market as Wal-Mart, Kraft and Home Depot pushed earnings up today. Both the DOW and NASDAQ were up 1% today, but this does little to mend the broken market returns of last week just yet.
My big surprise is the Biotech and Pharmaceuticals that don't rise much before big FDA decisions anymore. They seem to crash with the market and get oversold quickly before the big decisions. Jazz Pharma has been down heavily the past two sessions and others as of late have been slightly mixed before big FDA Decisions are looming.
Nonetheless here are today's Top Performers. Beat The Street on these stocks today. I like a lot of these upswing trades made today for Long-Term Growth.
Top Biotech Performers Tuesday
My big surprise is the Biotech and Pharmaceuticals that don't rise much before big FDA decisions anymore. They seem to crash with the market and get oversold quickly before the big decisions. Jazz Pharma has been down heavily the past two sessions and others as of late have been slightly mixed before big FDA Decisions are looming.
Nonetheless here are today's Top Performers. Beat The Street on these stocks today. I like a lot of these upswing trades made today for Long-Term Growth.
Top Biotech Performers Tuesday
8/12/10
Top BioPharma Performers Thursday August 12th
7/2/09
BioPharma Investor Blog
Okay, so now that I've started this I can update my progress on some stocks that I have purchased recently and maybe add a watchlist for those I am intending to watch closely and make a purchase.
Most stocks I purchase range in the 100-1000 range for shares purchased. I like to keep things easy to do the math in my head and it helps when you are tracking numerous stocks. I have a watchlist on CBS Marketwatch and have various newswires in my browser to get up to date stock information at a seconds hand. I keep up with most news through various Business Journals, and professional blogging sites. My favorites include SeekingAlpha.com, and Medpages news. Others I have stumbled across but Yahoo Finance, Google Searches on Clinical Trials and Biopharma news are really nice to have in todays digital age of up to the minute stock trading and research at a fingers touch.
My recent purchases have included Jazz Pharmaceutical(JAZZ), Spectrum Pharmaceutical (SPPI), Hemispherix BioPharma (HEB), Cyclacel (CYCC), and Spherix (SPEX). All Biopharma companies with empending Clinical Trial Data scheduled for release soon. My best pick so far is the Spectrum Pharma SPPI. I have learned how to use limit orders to chose the stock at the best price i feel it is worth. This is done with stock trending analysis. Simple Graph analysis, and most importantly the Financial Information as in the companies Liabilities, Assets, Debt Ratio, and Cash Flow analysis. All tools I have learned with my business training at NC State college of Business Management and Accounting.
I have worked for large and small companies and my main focus remains in the Biotech Pharmacuetical Market. I have tested samples for both Clinical Trials and have seen the likes of Pfizer, and Dendreon, and Savient. I live in a biopharma mecca and have lived in the Research Triangle Park now for over 3 years and love living in the Park as they call it. There is a large Indian Population so Namaste to everyone out in Morrisville, aka Little India. But anyways, I dont discriminate and love most people I run across. I value diversity and appreciate a change from everyday American Lifestyles.
But back to the stocks.
Up and Coming biopharma stocks include: AVI Biopharma (AVII), Exact Sciences Corporation (EXAS), most and any biopharma out of the Seattle Area ZGEN HGSI SGEN DNDN, and BDSI BioDelivery Sciences International.
Subscribe to:
Posts (Atom)